Altris AI
About Altris AI
Altris AI offers an advanced, AI-powered ophthalmic image management system designed to significantly enhance the diagnostic workflow for eye care professionals. The platform specializes in automated analysis of Optical Coherence Tomography (OCT) scans, capable of detecting and quantifying over 70 distinct retina pathologies and biomarkers. This includes prevalent conditions such as age-related macular degeneration (AMD), diabetic retinopathy (DR), and various forms of glaucoma, as well as less common retinal diseases like central retinal vein and artery occlusions, vitelliform dystrophy, and macular telangiectasia.
The system provides real-time diagnostic support by differentiating between pathological and non-pathological b-scans, performing quantitative analysis with precise area and volume measurements, and offering early glaucoma risk assessment through advanced optic disc and ganglion cell complex (GCC) analysis. Altris AI is vendor-neutral, compatible with OCT devices from multiple manufacturers, and facilitates consistent image interpretation and tracking of disease progression over time. This robust AI decision support aims to improve diagnostic accuracy, streamline clinical efficiency, and ultimately contribute to better patient outcomes by enabling earlier detection and more informed treatment decisions. The platform is FDA-cleared (510K), CE-certified, and adheres to HIPAA and GDPR compliance standards, ensuring data security and regulatory adherence.
Focus Areas
Business Intelligence
| Key Investors | Runa Capital, Joint Journey, Pharmaceutical Company Farmak, Artesian, Brinc Limited, University of Chicago Booth School of Business, Chicago Booth Angels, Digital Future, u.ventures, SID Venture Partners |
| Partnerships | Topcon Healthcare, Optopol, Huvitz, Carl Zeiss MediTech, Canon, Heidelberg Engineering, Visionix, Nikon (Optos), Nidek, Horizon Eye Care, AbbVie, Roche, Astellas, OD OS, OptoHellas, FinnGen, University of Helsinki |
| Acquisitions | None |
| Technology | Cloud-based SaaS platform, AI-powered medical image management system (Altris IMS), computer vision, deep learning algorithms, Altris Sync app for direct OCT device integration, vendor-neutral OCT compatibility |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, Altris AI acts as an intelligent co-pilot, enhancing diagnostic confidence and accuracy by providing a 'second opinion' and detecting subtle, early, or rare pathologies that might otherwise be missed. It significantly boosts efficiency by automating OCT scan analysis, reducing manual review time, and streamlining the workflow, allowing more time for direct patient interaction and personalized care. The platform's ability to provide clear, color-coded visuals and comprehensive reports also aids in patient education, fostering better understanding and trust. Furthermore, its vendor-neutrality ensures seamless integration with existing OCT devices, making it a versatile tool for various clinical settings.
Altris AI is a vendor-neutral platform, compatible with OCT devices from 8-9 major manufacturers. It offers an application, Altris Sync, to automatically transfer OCT scans directly from devices, eliminating manual upload steps. The system is designed to integrate seamlessly with existing clinical infrastructure, including EMR/EHR systems.
What the Web Says
Altris AI is an AI-powered ophthalmic image management system designed to assist ophthalmologists and optometrists in interpreting OCT scans and making diagnostic decisions. It helps differentiate pathological from non-pathological scans, define over 100 pathologies and pathological signs, and can accelerate OCT examinations. The software is praised for its innovative approach and ability to provide confidence to less experienced specialists.
Overall: PositiveStrengths
- Helps differentiate pathological scans from non-pathological OCT scans quickly.
- Defines over 100 pathologies and pathological signs, including rare and early-stage ones.
- Increases confidence for less experienced ophthalmologists and optometrists in OCT interpretation.
- Accelerates OCT examinations, allowing clinics to serve more patients.
- Seamless integration and outstanding customer support.
- FDA clearance, CE certification, and GDPR/HIPAA compliant.
Limitations
- Limited number of reviews on platforms like G2 and Capterra, making it difficult to provide comprehensive buying insight.
- One Reddit comment suggests that AI in general, while improving, still has a high margin of error in detecting normal anatomical differences versus concerning lesions.
- Some general AI training platforms mentioned on Reddit have issues with instability, low pay, or poor support, though these are not specific to Altris AI.
Based on reviews from: G2, Altris AI Reviews (from Altris AI website), Capterra, Software Advice, GetApp Australia, Slashdot, Reddit
Last updated: 2026-08-13
Videos
News, demos, and interviews about Altris AI.
Videos load interactively. If none appear, search YouTube for Altris AI →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Altris AI.
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]